Production, purification and validation of anti-tuberculosis IgY for diagnostic purposes

E. Aryan (Mashhad, Islamic Republic of Iran), M. Kouhi-Noghondar (Mashhad, Islamic Republic of Iran), M. Sankian (Mashhad, Islamic Republic of Iran), A. Arian (Mashhad, Islamic Republic of Iran), Z. Meshkat (Mashhad, Islamic Republic of Iran)

Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Aryan (Mashhad, Islamic Republic of Iran), M. Kouhi-Noghondar (Mashhad, Islamic Republic of Iran), M. Sankian (Mashhad, Islamic Republic of Iran), A. Arian (Mashhad, Islamic Republic of Iran), Z. Meshkat (Mashhad, Islamic Republic of Iran). Production, purification and validation of anti-tuberculosis IgY for diagnostic purposes. 4727

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The usefulness of antimycobacterial antibodies detection in TB diagnosis
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

Cloning, expression and purification of a recombinant lipid transfer protein and an αβ-gliadin from wheat: determination of the diagnostic impact by specific IgE-measurements
Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease
Year: 2009


Omics and single molecule detection: the future of TB diagnostics
Source: Eur Respir Mon 2012; 58: 144-153
Year: 2012


Monitoring of monoclonal antibody therapy with a new recovery ELISA assay technique (R-ELISA®)
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test
Source: Eur Respir J 2001; 18: Suppl. 33, 360s
Year: 2001

Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptides
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Compatibility of a novel filter paper-based bio-safe sputum transport kit with line probe assay for diagnosing drug-resistant tuberculosis: a single-site evaluation study
Source: ERJ Open Res, 7 (3) 00137-2021; 10.1183/23120541.00137-2021
Year: 2021



T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation
Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018
Year: 2018



A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


Rapid diagnostic methods: from urinary antigens to multiplex PCR
Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful?
Year: 2008


Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

The use of the lytic D29 mycobacteriophages for accelerated determination of the drug sensitivity of tuberculosis mycobacteria to first and second-line anti-TB drugs in clinical isolates obtained after initial cultivation
Source: Virtual Congress 2020 – Tuberculosis: part 2
Year: 2020




Diagnostic use of different isocyanate-albumin conjugates for detection of IgE antibodies in isocyanate workers
Source: Annual Congress 2009 - Occupational asthma in the clinic
Year: 2009

The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017

Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease
Source: International Congress 2017 – Update on TB: latest news
Year: 2017



Rapid detection of Mycobacterium tuberculosis from clinical specimens using a new target
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012

An immunochromatographic rapid test not suitable for TB screening
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009